摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Boc-L-Pro-indoline | 198218-53-0

中文名称
——
中文别名
——
英文名称
Boc-L-Pro-indoline
英文别名
tert-butyl (2S)-2-(2,3-dihydroindole-1-carbonyl)pyrrolidine-1-carboxylate
Boc-L-Pro-indoline化学式
CAS
198218-53-0
化学式
C18H24N2O3
mdl
——
分子量
316.4
InChiKey
MUFZLOBFHJPNMP-HNNXBMFYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    497.6±45.0 °C(Predicted)
  • 密度:
    1.199±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    23
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    49.8
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Boc-L-Pro-indoline三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 反应 2.0h, 以62%的产率得到(S)-1-prolylindoline
    参考文献:
    名称:
    借氢对α-氨基酯和酰胺进行N-烷基化
    摘要:
    开发了一种使用醇进行铱催化的氨基酯和酰胺直接烷基化的方法,该方法可以利用胺的游离碱和 HCl 盐。该反应通过借氢机制进行。
    DOI:
    10.1002/ejoc.202200152
  • 作为产物:
    描述:
    吲哚啉BOC-L-脯氨酸吡啶 作用下, 以 乙酸乙酯 为溶剂, 反应 16.0h, 以84%的产率得到Boc-L-Pro-indoline
    参考文献:
    名称:
    借氢对α-氨基酯和酰胺进行N-烷基化
    摘要:
    开发了一种使用醇进行铱催化的氨基酯和酰胺直接烷基化的方法,该方法可以利用胺的游离碱和 HCl 盐。该反应通过借氢机制进行。
    DOI:
    10.1002/ejoc.202200152
点击查看最新优质反应信息

文献信息

  • Tunable and Cooperative Catalysis for Enantioselective Pictet‐Spengler Reaction with Varied Nitrogen‐Containing Heterocyclic Carboxaldehydes
    作者:Yuk‐Cheung Chan、Marcus H. Sak、Scott A. Frank、Scott J. Miller
    DOI:10.1002/anie.202109694
    日期:2021.11.8
    We utilize diverse N-heterocyclic carboxaldehyde and regioisomers in Pictet-Spengler reaction. Compatibility was enabled by fine tuning the achiral carboxylic acid co-catalyst in the presence of chiral peptidic squaramide. Synthetic utility was demonstrated by stereoselective synthesis of pyridine-containing analogues of medicinally related molecules, including U.S. FDA approved drug Tadalafil.
    我们在 Pictet-Spengler 反应中利用多种N-杂环甲醛和区域异构体。通过在手性肽方酰胺存在下微调非手性羧酸助催化剂来实现兼容性。通过立体选择性合成医学相关分子的含吡啶类似物(包括美国 FDA 批准的药物他达拉非)证明了合成效用。
  • Stereoselective synthesis of E-64 and related cysteine proteases inhibitors from 2,3-epoxyamides
    作者:Francisco Sarabia、Antonio Sánchez-Ruiz、Samy Chammaa
    DOI:10.1016/j.bmc.2004.12.018
    日期:2005.3.1
    The stereoselective synthesis of cathepsin inhibitors from indoline type epoxyamides is described. The use of this type of epoxyamides permitted the preparation of E-64 and CA-074 related compounds depending on the order in which the key steps, the oxidation of indoline amides to indole amides and oxidative acetal cleavage were undertaken. By taking advantage of the facile substitution of the indole of the corresponding indole epoxyamides, with various nucleophiles, we were able to prepare different epoxysuccinic acids derivatives as potential cathepsin inhibitors. (C) 2004 Elsevier Ltd. All rights reserved.
  • Chiral Lewis Acid Controlled Synthesis (CLAC Synthesis): Chiral Lewis Acids Influence the Reaction Course in Asymmetric Aldol Reactions for the Synthesis of Enantiomeric Dihydroxythioester Derivatives in the Presence of Chiral Diamines Derived from L-Proline
    作者:Shū Kobayashi、Mineko Horibe
    DOI:10.1002/chem.19970030914
    日期:1997.9
    AbstractBoth enantiomers of 2,3‐dihy‐droxythioester derivatives were prepared with almost perfect stereochemical control by chiral Lewis acid controlled synthesis (CLAC synthesis). CLAC synthesis means synthesis of all individual diastereomers or enantiomers from the same starting materials by designing chiral Lewis acids. For example, (Z)‐1‐ethyl‐thio‐1‐(trimethylsiloxy)‐2‐(tert‐butyldi‐methylsiloxy)ethene (1) reacted with aldehydes in the presence of chiral tin(II) Lewis acids using (S)‐1‐methyl‐2‐[(isoin‐dolinyl)methyl]pyrrolidine (4) and (S)‐1‐methyl‐2‐[(indolinyl)methyl]pyrrolidine (5) to afford enantiomeric dihydroxy‐thioester derivatives. Chiral diamines 4 and 5, which were readily prepared from L‐proline, differ only in the fusion point of the benzene ring connected to the pyrrolidine moiety. The unique selectivities were ascribed to the conformational difference between the chiral tin(II) Lewis acids of chiral diamines 4 and 5, and the function of chiral sources for obtaining high selectivities has also been clarified.
  • CYANOPYRROLIDINES AS DUB INHIBITORS FOR THE TREATMENT OF CANCER
    申请人:MISSION THERAPEUTICS LIMITED
    公开号:US20180194724A1
    公开(公告)日:2018-07-12
    The present invention relates to novel compounds and method for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase L1 (UCHL1) and ubiquitin C-terminal hydrolase 30 or ubiquitin specific peptidase 30 (USP30). The invention further relates to the use of DUB inhibitors in the treatment of cancer and conditions involving mitochondrial dysfunction. Compounds of the invention include compounds having the formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 ,R 2 ,R 3 ,R 4 ,R 5 ,R 6 ,R 7 ,R 8 and R 9 are as defined herein.
  • <i>N</i> ‐Alkylation of α‐Amino Esters and Amides through Hydrogen Borrowing
    作者:Charlotte E. Coomber、Louis J. Diorazio
    DOI:10.1002/ejoc.202200152
    日期:2022.8.26
    A method for the iridium catalysed direct alkylation of amino esters and amides using alcohols, which can utilise both the free base and HCl salts of the amine, was developed. This reaction proceeds through a borrowing hydrogen borrowing mechanism.
    开发了一种使用醇进行铱催化的氨基酯和酰胺直接烷基化的方法,该方法可以利用胺的游离碱和 HCl 盐。该反应通过借氢机制进行。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物